Jynarque Kit
Product Images NDC 59148-080

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Jynarque (NDC 59148-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Otsuka America Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Kit Carton)

This is a medication called JYNARQUE (tolvaptan) available in a carton containing 56 tablets in child-resistant weekly packs. Each weekly pack has a blister pack with 14 tablets, each of which is 15mg. The medication guide enclosed should be given to each patient. The medication should be kept out of reach of children and stored at a temperature between 20°C and 26°C. The recommended dose of each triangular tablet is 16mg, and further information can be found in the prescribing instructions. The name of the manufacturer is Pramaceuto Co. L1 in Tokyo, Japan.*

FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Carton)

FDA Label Image

Principal Display Panel (Kit Carton)

This is a medication package of Jynarque (Tolvaptan) tablets that comes in a blister card with 56 tablets of 7x30mg and 7x16mg each. The package is a monthly carton that includes four child-resistant weekly packs. The recommended dosage is not available in the given text, and the package has an enclosed medication guide for each patient. The tablets contain 30mg or 16mg of Tolvaptan and should be stored at a temperature between 15°C and 30°C. It is manufactured by Otsuka America Pharmaceutical Inc. This is helpful for someone who wants to know the contents of the medication package.*

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Carton)

FDA Label Image

Principal Display Panel (Kit Carton)

JYNARQUE is a medication used for treating certain conditions, and comes in a monthly carton that includes four child-resistant weekly packs. Each weekly pack contains one blister card with 14 tablets. The tablets themselves come in two different dosages -7 x 46 mg tablets and 7 x 16 mg tablets. The medication guide needs to be dispensed to each patient. The medication should be stored between 59°F-84°F and out of reach of children. Each square tablet contains 45 g of tolvaptan, and each triangular tablet contains 15 mg of tolvaptan. For recommended dosage and further information, please refer to the prescribing information label.*

FDA Label Image

Principal Display Panel (Kit Carton)

This is a description of a medication called JYNARQUE. Enclosed are 56 tablets in a monthly carton for prescription use only. There are four child-resistant weekly packs. Each weekly pack contains 1 blister card with 14 tablets, 7 of 60mg and 7 of 30mg. Recommended dosage should be seen in prescribing information. The modified rectangular tablet contains 60mg of fovaptan, while each round tablet contains 30mg of fovaptan. The medication guide should be given to each patient and kept away from children. The medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F).*

FDA Label Image

Principal Display Panel (Kit Carton)

This is a medication guide for JYNARQUE which details its composition and dosage recommendation. Each pack of JYNARQUE contains 56 tablets. It has four child-resistant weekly packs, and each pack has a blister card containing 14 tablets. Each tablet is either a 90 mg folvaptan pentagonal tablet or a 30 mg folvaptan round tablet. The recommended dosage is specified in the prescription information, and it is advised to keep it out of children's reach and at a controlled room temperature. The manufacturer is G and P Laboratories, and the distributor is Otsuka America Pharmaceutical, Inc.*

FDA Label Image

Chemical Structure (Jynarque Chem Structure)

FDA Label Image

Principal Display Panel (15-15 mg Sleeve)

FDA Label Image

Principal Display Panel (15 mg Tablet LBL)

FDA Label Image

Principal Display Panel (30-15 mg Sleeve)

Weekly Pack contains JYNARQUE tablets, which are only available with a prescription. The pack contains 14 tablets with a combination of 30 mg and 15 mg tablets, and the NDC code is 59148-080-07. The instructions indicate how to open the foil package by pressing and holding the perforated button and then pulling out the package. Additionally, there is information about the medicine included in the pack.*

FDA Label Image

Principal Display Panel (30 mg Tablet LBL)

FDA Label Image

Principal Display Panel (45-15 mg Sleeve)

The text appears to be a combination of instructions for taking medicine, details of its packaging, and some gibberish. It seems like it is a pack of 14 tablets, with 7 of 45 mg and 7 of 15 mg. The medicine is called "JYNARQUE (tolvaptan) tablets" and requires a prescription. It also includes some instructions on how to take the medication, like pressing a button and pushing the pill through the packaging. However, due to the limited text and gibberish, it is not possible to provide a more detailed or specific description.*

FDA Label Image

Principal Display Panel (60-30 mg Sleeve)

FDA Label Image

Principal Display Panel (90-30 mg Sleeve)

This is a pharmaceutical product that contains Tolvaptan tablets and is designed as a weekly pack. It includes instructions on how to open the pack and take the medication. The package contains 14 tablets of different dosages. The text also contains some characters that are not English.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.